Fig. 1From: Long-term response of metastatic hereditary leiomyomatosis and renal cell carcinoma syndrome associated renal cell carcinoma to bevacizumab plus erlotinib after temsirolimus and axitinib treatment failuresPatient pedigree showing individuals with uterine myoma, skin leiomyoma, renal cysts, and renal cell carcinomaBack to article page